Literature DB >> 17132222

Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivo.

Arkadiusz Welman1, Christopher Cawthorne, Lourdes Ponce-Perez, Jane Barraclough, Sarah Danson, Stephen Murray, Jeff Cummings, Terry D Allen, Caroline Dive.   

Abstract

The levels and activity of c-Src in colorectal cancer cells increase steadily during the course of colorectal carcinogenesis and are most highly elevated in advanced metastatic disease. However, the effects of increases in c-Src activity on the proliferation of colorectal cancer cells during early and late stages of tumorigenesis remain elusive. To study the consequences of increases in c-Src levels and activity on the growth of colorectal cancer cells in later stages of colorectal carcinogenesis, we developed human colorectal cancer cell lines in which c-Src levels and activity could be inducibly increased by a tightly controlled expression of wild-type c-Src or of the constitutively active mutant of c-Src, c-SrcY527F. Src induction activated multiple signaling pathways (often associated with a proliferative response) but promoted neither cell proliferation in vitro nor tumor growth in a xenograft model in vivo. These results indicate that, in more advanced stages of colorectal carcinogenesis, increases in c-Src levels and activity are likely to have functions other than the direct promotion of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132222      PMCID: PMC1716016          DOI: 10.1593/neo.06475

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  40 in total

Review 1.  Checking out the G(2)/M transition.

Authors:  V A Smits; R H Medema
Journal:  Biochim Biophys Acta       Date:  2001-05-28

2.  Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.

Authors:  Heike Aligayer; Douglas D Boyd; Markus M Heiss; Eddie K Abdalla; Steven A Curley; Gary E Gallick
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

3.  Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.

Authors:  M M Moasser; M Srethapakdi; K S Sachar; A J Kraker; N Rosen
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

4.  SRC transcriptional activation in a subset of human colon cancer cell lines.

Authors:  S Dehm; M A Senger; K Bonham
Journal:  FEBS Lett       Date:  2001-01-05       Impact factor: 4.124

5.  The mechanism of cell cycle regulation by v-Src.

Authors:  D Riley; N O Carragher; M C Frame; J A Wyke
Journal:  Oncogene       Date:  2001-09-20       Impact factor: 9.867

6.  Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.

Authors:  J Gayet; X P Zhou; A Duval; S Rolland; J M Hoang; P Cottu; R Hamelin
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

7.  Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2.

Authors:  Arkadiusz Welman; Jane Barraclough; Caroline Dive
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 8.  Role of Src expression and activation in human cancer.

Authors:  R B Irby; T J Yeatman
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

Review 9.  The hunting of the Src.

Authors:  G S Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

10.  Involvement of c-Src in carcinoma cell motility and metastasis.

Authors:  M Sakamoto; M Takamura; Y Ino; A Miura; T Genda; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  2001-09
View more
  13 in total

Review 1.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

2.  Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters.

Authors:  Christopher J Morrow; Mohammad Ghattas; Christopher Smith; Heinz Bönisch; Richard A Bryce; D Mark Hickinson; Tim P Green; Caroline Dive
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

3.  TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB.

Authors:  Y Ye; L M Pringle; A W Lau; D N Riquelme; H Wang; T Jiang; D Lev; A Welman; G A Blobel; A M Oliveira; M M Chou
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

4.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.

Authors:  Jane Barraclough; Cassandra Hodgkinson; Alison Hogg; Caroline Dive; Arkadiusz Welman
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

6.  Protein kinase C delta is phosphorylated on five novel Ser/Thr sites following inducible overexpression in human colorectal cancer cells.

Authors:  Arkadiusz Welman; John R Griffiths; Anthony D Whetton; Caroline Dive
Journal:  Protein Sci       Date:  2007-10-26       Impact factor: 6.725

7.  CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.

Authors:  Anderly C Chüeh; Gahana Advani; Momeneh Foroutan; Jai Smith; Nadia Ng; Harshal Nandurkar; Daisy S Lio; Hong-Jian Zhu; Yuh-Ping Chong; Heather Verkade; Donald J Fujita; Jeffrey Bjorge; Faiza Basheer; Jet Phey Lim; Ian Luk; Amardeep Dhillon; Anuratha Sakthianandeswaren; Dmitri Mouradov; Oliver Sieber; Frédéric Hollande; John M Mariadason; Heung-Chin Cheng
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

8.  v-Src Causes Chromosome Bridges in a Caffeine-Sensitive Manner by Generating DNA Damage.

Authors:  Masayoshi Ikeuchi; Yasunori Fukumoto; Takuya Honda; Takahisa Kuga; Youhei Saito; Naoto Yamaguchi; Yuji Nakayama
Journal:  Int J Mol Sci       Date:  2016-06-02       Impact factor: 5.923

9.  Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model.

Authors:  Christopher Cawthorne; Ric Swindell; Ian J Stratford; Caroline Dive; Arkadiusz Welman
Journal:  J Biomol Tech       Date:  2007-04

10.  Tetracycline regulated systems in functional oncogenomics.

Authors:  Arkadiusz Welman; Jane Barraclough; Caroline Dive
Journal:  Transl Oncogenomics       Date:  2007-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.